ArticleInvestigational new drugs2020

NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.

Ana M Molina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.